Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Early-access programme in emergency care

idarucizumab use for rapid dabigatran reversal in critical care patients

Elalamy, Ismaila; Crisan, Oliviub; Gruenenfelder, Fredrike; Benarousse, Gaêllec; Tazarourte, Karimd

European Journal of Emergency Medicine: June 2019 - Volume 26 - Issue 3 - p 230–231
doi: 10.1097/MEJ.0000000000000574

aService d’Hématologie Biologique Hôpital Tenon, HUEP AP-HP Sorbonne Université Paris, INSERM UMRS 938

bMedical Affairs

cRegulatory Affairs, Boehringer Ingelheim, Paris

dEmergency Department CHU Edouard Herriot, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France

eGlobal Pharmacovigilance, Boehringer Ingelheim International GmbH, Germany

Received 19 April 2018 Accepted 8 August 2018

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website,

Correspondence to Ismail Elalamy, MD, Service d’Hématologie Biologique Hôpital Tenon, 4 Rue de la Chine, 75020 Paris, France Tel: + 33 156 017 718; fax: + 33 156 016 044; e-mail:

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.